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Introduction
Low back pain is a leading cause of years lived with disa-
bility (affecting ~80%–90% of people worldwide), and 
together with degenerative conditions of the intervertebral 
disc (IVD), represents a global socioeconomic and medi-
cal burden.1–3 The IVD is located between adjacent verte-
brae in the spinal column and is made up of the nucleus 
pulposus (NP), anulus fibrosus, and cartilaginous end-
plates.4,5 These structures collectively distribute mechani-
cal forces applied to the axial skeleton during activities of 
daily living and contribute flexibility to the spine.6–11 The 
degenerative cascade in the IVD is thought to initiate in 
the NP structure with changes including tissue dehydration 
and stiffening and a subsequent loss of disc height.1,4,12,13 
Patients who present clinically with these changes may 
also experience impaired physical function, pain upon 
motion, and associated disability.1,14,15
When in a healthy, “juvenile” state, the NP is avascular 
and aneural and contains cells derived from the notochord 
embedded in a soft (~0.5–1 kPa), highly hydrated (~90% 
water by wet weight) matrix.16–20 This extracellular matrix 
contains proteoglycans (including aggrecan), collagens 
(largely type II), and laminins, amongst other pro-
teins.11,17,21–23 Aging and degeneration, however, result in 
altered extracellular matrix biosynthesis for cells of the NP 
including increased collagen type I and reduced aggrecan 
production; the relative loss of proteoglycan results in 
decreased water content and a stiffening of the matrix (10–
20 kPa).18,19,21,24–27 The NP cells also undergo changes with 
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maturation and shift from an anabolic, notochord-like phe-
notype (characterized by large, circular, vacuolated cells in 
robust clusters) to an altered state in which the cells assume 
an elongated cell shape, lose their vacuoles, and have 
reduced biosynthetic capacities.11,17,18,25,26,28 As the NP has 
a limited intrinsic ability for self-repair, these alterations 
contribute to a feedforward degenerative cascade that 
results in progressive damage to the IVD across length 
scales, motivating an interest in regenerative engineering 
approaches for NP and IVD repair.7,15,24,25
Biomaterial and tissue engineering strategies for the 
IVD have been sought as a method to restore characteris-
tics of the native tissues’ structure and function.29,30 A large 
body of work has demonstrated an ability to functionalize 
polymers with bio-adhesive ligands which are often either 
full-length extracellular matrix proteins, or else, small 
peptide sequences derived from a constituent of the extra-
cellular matrix.31–37 These approaches offer the opportu-
nity to engineer bioactive materials that promote cell 
attachment and modulate cell behaviors.29,38 While full-
length proteins and short peptides have both been utilized 
for this purpose, the incorporation of peptides in biomate-
rial design has several advantages over full-length proteins 
- short peptides possess increased stability and can be 
more economic.39,40 Additionally, small peptide sequences 
offer the ability to provide controlled sites of biomaterial-
cell interactions.39,40
Laminins are a compositionally minor component of 
the IVD extracellular matrix that have been shown to play 
important roles in facilitating cell attachment and mecha-
notransduction by interacting with cells through cell-mem-
brane receptors including integrins and syndecans.41–43 NP 
cell interactions with soft (<1 kPa) biomaterials function-
alized with full-length laminin proteins have been shown 
to promote cell attachment, cell clustering, increased bio-
synthesis of sulfated glycosaminoglycans, and increased 
expression of NP cell markers including integrin α3 and 
cytokeratin 8.44,45 Whereas, similarly soft biomaterials that 
were either unfunctionalized or conjugated with collagen 
type II did not elicit these same responses.44,45 Together 
these findings demonstrate that NP cells recognize cues 
from the laminin and modulate cellular behaviors in 
response. Full-length laminin proteins, however, contain 
hundreds of identified bioactive amino acid sequences 
across the α, β, and γ chains33,46 which can contribute to 
uncontrolled cellular interactions. Studies conducted over 
the past several decades have begun to elucidate the adhe-
sive capabilities of laminin-mimetic peptides (LMPs), 
their role in promoting cell spreading or other cell behav-
iors, and the cell surface receptors that recognize each seq-
uence.33,47–53 There is therefore an opportunity to use 
targeted LMPs to mimic the function of full-length 
laminins in biomaterial design for IVD regeneration.
In prior work, select LMPs (from the globular domain 
of the α laminin chain including AG73, IKVAV, AG10, 
and GD-6) were conjugated to polyacrylamide and 
screened for an ability to promote behaviors consistent 
with healthy NP cells – cell attachment, production of sul-
fated glycosaminoglycans (sGAGs), and expression of 
aggrecan, N-cadherin, GLUT1, and collagen I/II mRNA.40 
In follow-on work, we recently developed an LMP-
functionalized biomaterial using a poly(ethylene) glycol 
(PEG) backbone.54 PEG was chosen from amongst other 
hydrogel systems commonly used for NP repair29,55,56 as it 
is clinically relevant,57,58 offers independent control of 
substrate stiffness and peptide density,54 and allows for the 
bioactive component of the hydrogel to be controlled 
solely by the ligands functionalized to it.29,45,54 While gels 
made of 4% PEG (0.3–0.6 kPa) approximate the stiffness 
of the healthy human NP ECM16,19,24 and have demon-
strated an ability to promote de-differentiation in degen-
erative NP cells,45,54,59 stiff gels may have advantages for 
clinical use including improved handling properties and 
better integration with the native ECM.60,61 Characterization 
of human NP cell attachment, morphology, cytoskeletal 
organization, and protein/gene expression profiles revealed 
an ability for stiff (15% PEG, 10.5 kPa) gels functionalized 
with 100 µM of peptide (50 µM AG73 in combination with 
50 µM IKVAV) to recapitulate behaviors seen on soft PEG 
gels functionalized with full-length laminin (LM-111).54 
This finding corroborates that stiffness alone is not the 
master variable controlling the NP cell phenotype, and that 
peptide density and sequence are important variables in 
designing a bioactive, clinically relevant, material for NP 
cell support.
In the present study, a library of biomaterials was syn-
thesized using the peptide-functionalized PEG hydrogel 
strategy to support development of biomaterials that pre-
sent a range of LMPs in order to regulate NP cell behav-
iors. An initial list of candidate peptides from laminin 
isoforms present in the NP ECM21,23,37,62,63 was created and 
narrowed based on the reported ability of the peptide 
sequences to support cell attachment and in keeping with 
the cell surface receptors believed to mediate attachment 
for NP cells. The integrin-binding LMPs (YIGSR, P4, 
A5G81, GD-6, and IKVAV) used herein (Figure 1) were 
chosen based on prior literature which has validated their 
ability to promote attachment of NP cells or other cell 
types through integrins including α3 and α6,40,54,64–68 pro-
teins known to be expressed in NP cells.41,42 The syndecan-
binding peptide AG73 was also chosen for evaluation 
based on prior work suggesting that AG73 can facilitate 
NP cell attachment.40,54 The objective of this work was to 
evaluate the effects of presenting integrin-binding and 
syndecan-binding peptides individually or in combination 
upon the peptide-functionalized PEG hydrogels as meas-
ured by the ability of the biomaterial to promote NP cell 
attachment, modulate cell morphology, engage mechano-
sensitive signaling pathways, and regulate protein/gene 
expression.
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Figure 1. Laminin-mimetic peptides used to functionalize PEG hydrogels. (Left) Table of peptides, amino acid sequence, location 
on laminin protein, and putative cell surface receptors. (Right) Location of peptide sequences on the laminin protein, created with 
BioRender.com. 
blue: syndecan-binding peptide; red: integrin-binding peptides.
Methods and materials
Primary human NP cell culture
NP tissue was obtained from to-be-discarded surgical 
waste tissues of anonymized patients (only sex, age and 
race were recorded; ages 16–75, male and female) receiv-
ing surgical treatment for degenerative conditions of the 
IVD. NP cells were enzymatically isolated from tissues as 
previously described.54,69,70 Briefly, NP tissue was digested 
at 37°C for 2–4 h (0.2% pronase (Roche; Basel, 
Switzerland), 0.4% collagenase type II (Worthington 
Biochemical; Lakewood, NJ), and 5% Fetal Bovine Serum 
(FBS); 23 ml per gram tissue). The resulting solution was 
passed through a 70 µm filter in order to isolate the NP 
cells which were then expanded in monolayer culture 
using Ham’s F12 media (Life Technologies; Carlsbad, 
CA) supplemented with 1% penicillin/streptomycin and 
10% FBS under 5% CO2 and atmospheric O2 at 37°C. 
Expanded cells were used for experimentation at passages 
0–4; all experiments made use of multiple samples (bio-
logical replicates) from at least three human subjects with 
assay-specific sample sizes as detailed below.
Formation of hydrogels
Laminin-mimetic Peptide (LMP) Hydrogels 15% PEG 
hydrogels (% w/v; ~10.5 kPa) were formulated as previ-
ously described.54 Briefly, 8-arm star PEG terminated with 
maleimide (PEG-8MAL, MW 20 kDa) and PEG-dithiol 
(SH-PEG-SH, MW 600 Da) were obtained from Creative 
PEGWorks (Durham, NC). Cysteine-terminated lyophilized 
peptides (YIGSR, P4, A5G81, GD-6, IKVAV, and AG73; 
sequences listed in Figure 1, GenScript Biotech, Piscataway, 
NJ) and PEG-MAL were each dissolved in 1X PBS (pH 
3.25; acidic conditions were used to control reaction 
speed54,71) and combined to achieve a final total peptide 
concentration of 100 µM and functionalization of the PEG 
backbone through a maleimide-thiol Michael-type addition 
reaction. Gels were functionalized with a single peptide 
(100 µM) or with two peptides (dual peptide; 50 µM of each 
to achieve a total of 100 µM). Separately, PEG-dithiol was 
also dissolved in 1X PBS pH 3.25. To form gels (at room 
temperature), the PEG-dithiol crosslinker was added to the 
PEG-MAL and peptide solution in order to initiate gelation 
through a second maleimide-thiol Michael-type addition 
reaction (Figure 2, Supplemental Figure 1). Gel solution 
was pipetted into chamber slides (Nunc Lab-Tek Chamber 
Slide Systems™, ThermoFisher Scientific, Waltham, MA) 
or well plates as needed for subsequent assays. Gels were 
neutralized in 1X PBS pH 7.4 and allowed to swell over-
night at 4°C before use for experimentation.
Hydrogels Functionalized with LM-111 4% PEG gels pre-
senting full-length laminin (LM-111) were prepared as 
previously described (Supplemental Figure 1).45,54,59 
PEGylated laminin (PEGLM) was formed by reacting 
Acrylate-PEG-hydroxysuccinimide (Ac-PEG-NHS, 10 kDa, 
Creative PEGWorks; Winston-Salem, NC) with laminin-111 
(Trevigen; Gaithersburg, MD). Unreacted Ac-PEG-NHS was 
removed by dialyzing the PEGLM solution against PBS. The 
concentration of PEGLM was determined via 280 nm absorb-
ance and then diluted in 1X PBS (pH 7.4) to 0.5 mg/ml and 
allowed to react with 8-arm PEG-Ac (4% w/v; 10 kDa; 
Creative PEGworks) and 10% (v/v) Irgacure 2959 (BASF, 
Ludwigshafen, Germany). Polymerization occurred upon 
exposure to UV light and gels were allowed to swell over-
night in 1X PBS pH 7.4. Material characterization of both the 
PEG-peptide and PEGLM gels has been previously reported 
and the hydrogel stiffness has been shown to be a function of 
PEG incorporation rather than ligand density.45,54,59 15% PEG 
gels have been shown to produce gels with a bulk substrate 
stiffness of 10.5 kPa,54 while 4% PEG creates a hydrogel of 
0.3–0.6 kPa.54,59
Characterization of NP attachment to 
hydrogels
Percent Cell Attachment 20,000 cells were seeded on 
hydrogels (LMP or PEGLM) or untreated chamber slides 
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(negative control) and allowed to attach for 24 h. The cells 
were then fixed in 4% paraformaldehyde (PFA, 10 min), 
permeabilized with Triton-X (0.2% diluted in PBS+/+, 
10 min), and blocked with 3.75% bovine serum albumin 
and 5% nonimmune goat serum for 30 min. Samples were 
then stained with phalloidin (1:200, Alexa Fluor-488, 
Invitrogen, Carlsbad, CA) to visualize the actin cytoskel-
eton; nuclei were counterstained with DAPI (2 µg/mL, 
Sigma Aldrich, St. Louis, MO). For each sample, a mini-
mum of five regions of interest (ROI) were imaged across 
the gel using confocal microscopy (TCS-SPE with DM6 
RGBV confocal microscope; Leica DFC7000T camera; 
using Leica LAS X core software; Leica Microsystems, 
Wetzlar, Germany).
Nuclei were counted in the ROIs and total cell attach-
ment was calculated by extrapolating the cell number 
determined from the ROIs to the full area of the gel. 
Percent cell attachment was calculated as 100*(calculated 
cell attachment number/seeded cell number) that is, 
100*(the extrapolated value/20,000 cells).
Cell Morphology From the imaged ROIs, cell morphol-
ogy was categorized as single cells, small clusters (2–3 
cells) or large cell clusters (4+ cells).44 Fiji software72 was 
used to quantify circularity and spread area for cells attach-
ing as single cells or clusters.
Statistical Analysis of cell attachment and cell mor-
phology Assays to measure cell attachment and morphol-
ogy were performed for each of three separate human 
tissue samples (biological replicates) per hydrogel condi-
tion and a minimum of 70 cells were visualized per human 
subject. In order to test for differences in percent cell 
attachment and cell morphology amongst the single-pep-
tide gels (YIGSR, P4, A5G81, GD-6, IKVAV, and AG73), 
one-way ANOVAs (factor (1) = peptide, levels (6) = pep-
tide sequence) were performed with Tukey’s multiple 
comparisons tests with repeated measures. Additionally, in 
order to compare the effects of the LMP gels to biomateri-
als presenting the full-length laminin, repeated measures 
one-way ANOVAs with a Dunnett’s multiple comparison 
were used to test patient-matched data for differences in 
cell behaviors on the single-peptide gels compared to that 
observed on 4% PEGLM. Two-tailed t-tests were used to 
compare cell behavior metrics on gels with dual presenta-
tion of LMPs (ex. YIGSR + AG73) to gels functionalized 
with a single LMP (ex. YIGSR alone or AG73 alone).
Quantifying Effect of Integrin Blocking on Cell 
Attachment In order to assess the integrin subunits that 
mediate NP cell attachment to LMPs, integrin blocking 
was performed. Cells were serum-starved overnight before 
use for this assay. After being trypsinized and neutralized 
in trypsin soybean inhibitor, cells (10,000 cells per well) 
were incubated with integrin blocking or isotype control 
antibodies (1:50) for 30 min at 37°C before seeding on 
LMP gels in chamber slides (Table 1). After 2 h, cell attach-
ment was quantified using the CellTiter-Glo (Promega, 
Madison, WI) assay according to manufacturer’s protocol 
and previous studies.40,54,58 Relative attachment to LMP 
gels was calculated as 100*(cell attachment in samples 
treated with integrin blocking antibodies/samples treated 
with IgG control antibody). A total of six technical repli-
cates were quantified for each condition from three bio-
logical replicates. One-tailed paired t-tests were used to 
test for reductions in cell attachment between integrin 
blocked- and IgG-treated samples.
Quantifying protein phosphorylation
Bioactivity of the gels was assessed by measuring phos-
phorylation of ERK 1/2 and GSK3β using AlphaLISA kits 
(PerkinElmer, Waltham, MA) per the manufacturer’s pro-
tocol with the following modifications. Serum-starved NP 
cells were seeded on LMP or PEGLM gels (10,000 cells 
per gel in 96 1/2 area well) and cultured at 37°C for 15 min 
(ERK 1/2) or 120 min (GSK3β). These timings were deter-
mined based on preliminary experiments (data not shown) 
and are consistent with previous protocols.58,73–75 After the 
appropriate culture time, the media was gently aspirated 
from the wells containing the gels and the lysis buffer was 
Figure 2. Schematic demonstrating gel formation and subsequent experimentation. PEG hydrogels can be functionalized with an 
integrin-binding peptide (red) and/or a syndecan-binding peptide (blue) using maleimide-thiol based Michael-type addition reactions. 
Image created with BioRender.com.
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applied for 10 min to lyse adherent cells. The solution was 
then transferred to empty wells into which the acceptor 
and donor buffers were subsequently added; this was done 
in order to avoid interference from the gel. Six technical 
replicates were quantified for each gel and protein (ERK 
1/2 and GSK3β) from three biological replicates. One-way 
ANOVAs were performed to test for differences in protein 
phosphorylation amongst single-peptide gels (Tukey’s 
multiple comparisons test) or compared to PEGLM 
(Dunnett’s multiple comparison test).
Characterization of gene expression of 
phenotypic markers
RT-qPCR was conducted to assess expression of genes 
characteristic of juvenile NP cells.28 A total of 300,000 
cells were seeded on each gel condition. After 4 d of cul-
ture on 15% PEG LMP-functionalized or 4% PEGLM 
gels, RNA was extracted, reverse transcribed to cDNA, 
and qPCR was performed to quantify expression of ACAN, 
CDH2, GLUT1, COL2A1, and COL1A1 (Table 2). The 
∆∆Ct method was used to compare expression of pheno-
type markers first to the housekeeping genes 18S and 
GAPDH and then to cells cultured on AG73-functionalized 
gels. This analysis allowed for the comparison of single 
integrin-binding LMP gels to the syndecan-binding gel 
and also allowed dual peptide gels to be compared to sin-
gle peptide gels. To provide a reference by which 
to visualize the gene expression data from the LMP gels 
compared to the full-length protein, gene expression for 
cells cultured on 4% PEGLM was also quantified (using 
the same ∆∆Ct method – normalized first to housekeeping 
genes and then to the AG73-functionalized gels). Gene 
expression was quantified for each condition as obtained 
from 3 to 5 biological replicates. Radar plots were gener-
ated using LiveGap Charts (https://charts.livegap.com) in 
order to visualize patterns in gene expression between sub-
strate conditions.
Characterization of protein expression and 
nascent protein production
Further characterization of protein expression on a subset 
of gels was utilized to confirm that the LMPs are able to 
support focal adhesion formation, biosynthesis, and intra-
cellular signaling through an additional mechanotransdu-
cive pathway (YAP/TAZ). Expanded descriptions of 
immunolabeling processes are described below. Briefly, 
following 4 d of cell culture on A5G81- or IKVAV-
functionalized gels (10,000 cells per gel in an 8-well 
chamber slide), cells were fixed using 4% PFA, permeabi-
lized, and immunolabeled as described below with nuclei 
counterstained using DAPI. An average of 5 ROIs were 
imaged for each gel and each human subject such that a 
minimum of 35 cells were quantified for each protein 
respectively as obtained from three biological replicates. 
Table 1. Primary antibodies utilized for immunocytochemistry and integrin blocking.
Antibodies for Immunocytochemistry
Target Species; Dilution Manufacturer
YAP Mouse; 1:100 Santa Cruz Biotechnology
Paxillin Rabbit; 1:100 Abcam
Antibodies for live-cell integrin blocking (azide-free, 20 µg/mL)
Integrin Anti-integrin antibody Control IgG antibody
α3 Clone P1B5 (MilliporeSigma) Mouse IgG1 (ThermoFisher Scientific)
Abcam, Cambridge, UK; MilliporeSigma, St. Louis, MO; Santa Cruz Biotechnology, Dallas, TX; Thermo Fisher Scientific, Waltham, MA.
Table 2. Primers for qRT-PCR.




SLC2A1 (GLUT1) Glucose transporter 1 Hs00892681_m1
COL2A1 Collagen type II Hs00156568_m1
COL1A1 Collagen type I Hs00164004_m1
GAPDH Glyceraldehyde 3-phosphate dehydrogenase (Housekeeping Gene) 4332649
18S 18S Ribosomal RNA (Housekeeping Gene) Hs99999901_s1
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Two-tailed t-tests were performed to assess whether differ-
ences in these cell behaviors were observed between the 
two gel conditions.
Quantification of Focal Adhesions To assess the cell-
gel interactions, cells on A5G81 or IKVAV gels were 
stained using anti-paxillin antibodies or respective iso-
type controls (Table 1) and an Alexa Fluor secondary 
antibody (1:200). The samples were imaged as previ-
ously described and quantification of focal adhesion area 
was performed in Fiji software according to previously 
reported protocols.54,72,76
Quantification of YAP Localization Cells on IKVAV or 
A5G81 gels were stained using a mouse anti-YAP primary 
antibody (1:100; Table 1) or respective isotype controls 
and an Alexa Fluor secondary antibody (1:200). Sample 
ROIs were then imaged as previously described. Nuclear 
and cytoplasmic localization was quantified in Fiji by 
measuring expression of YAP in regions with DAPI stain-
ing (nuclear YAP) and in the extra-nuclear space of the cell 
body (cytoplasmic YAP). YAP signal was reported as the 
ratio of nuclear to cytoplasmic protein expression.54,59
Characterization of Biosynthesis Additionally, the bio-
synthetic capacities of cells cultured on the A5G81 or 
IKVAV gels were quantified. Fluorescence non-canonical 
amino acid tagging (FUNCAT) imaging was used to quan-
tify intracellular biosynthesis and extracellular protein 
deposition as previously described.77–79 Briefly, two media 
solutions were prepared for use in cell culture – DMEM 
(without HEPES, sodium pyruvate, L-methionine, 
L-cysteine, or L-glutamine) was supplemented with 10% 
FBS, ascorbic acid (Sigma Aldrich), sodium pyruvate 
(Thermo Fisher Scientific), glutamax (1:100, Thermo 
Fisher Scientific), 1% penicillin/streptomycin, L-cysteine 
(Sigma Aldrich), and either L-methionine (control media, 
Sigma Aldrich) or AHA (L-azidohomoalanine, an analog 
for L-methionine used for the labeling media, Click 
Chemistry Tools; Scottsdale, AZ). Cells (10,000 cells per 
gel in an 8-well chamber slide) were seeded on IKVAV- or 
A5G81-functionalized gels and cultured for 4 d in the 
media that containing either the amino acid methionine or 
the methionine analog (AHA). After this culture period, 
the media was removed and the samples were incubated 
for 40 min (37°C, 5% CO2) with DBCO-488 (5 mM 
DBCO-488 diluted 1:165 in PBS with 1% BSA; Click 
Chemistry Tools) to label the proteins which incorporated 
AHA. The samples were then washed, fixed with 4% PFA 
(10 min), permeabilized in 0.2% Triton-X (10 min), 
and stained with AlexaFluor phalloidin-633 and DAPI 
(2 µg/mL) to visualize cytoskeleton and nuclei, respec-
tively. The samples were imaged as previously described 
for immunostaining (SPE DM6 Leica confocal micros-
copy) in order to obtain 2D confocal images. Nascent 
intracellular protein biosynthesis was assessed by quanti-
fying the mean fluorescence intensity of the DBCO chan-
nel in the region within the cell body (as determined by 
co-localization with the phalloidin stain) and extracellular 
protein deposition was quantified by examining the fluo-
rescence located outside of the cell body.
Dimensionality reduction
As previously described, cell behaviors were characterized 
on the LMP gels through multiple measures of NP cell 
phenotype. It is not well understood how distinct types of 
NP cell responses contribute to the overall NP cell pheno-
type. Therefore, analysis was performed to distill the 
multi-dimensional data presented in order to better under-
stand the interplay between cell behaviors and the cues 
provided by the LMP gels. A data matrix was made repre-
senting the average value of the results of those cell behav-
ior metrics which were assessed on all gel conditions (cell 
attachment, spread area of single cells, spread area of clus-
tered cells, % of cells clustered, circularity of single cells, 
cell attachment following integrin α3 blocking, and gene 
expression (ACAN, CDH2, GLUT1, COL2A1, and 
COL1A1) from biological replicates obtained from three 
human patients.
Using this data matrix, correlation analysis was calcu-
lated in Prism GraphPad (v9 San Diego, CA). A correla-
tion matrix (of correlation coefficient, r, values) was 
produced within the software as the result of pairwise lin-
ear correlations calculated between each of the metrics in 
order to determine cell behaviors which might be co-regu-
lated in NP cells. Principal components analysis (PCA) 
was also performed in Prism GraphPad. In order to elimi-
nate variability introduced by simultaneous study of vari-
ables with distinct ranges of values, the data were scaled 
for a mean of zero and a standard deviation of 1 for each 
variable. PCA was performed on this scaled data matrix 
and the eigenvalues were used to identify the variance cap-
tured by each principal component (PC). Furthermore, the 
PC scores were used to identify the clustering of LMP gel 
conditions, and the loadings provided insight into the rela-
tive contributions of measured cell behavior metrics to the 
variance captured in both PC 1 and 2.
Additionally, “leave one out” validation was performed 
within Prism GraphPad using the following method in 
order to identify the relative ability of a cell behavior to 
predict a given gene’s expression. First, a training set was 
constructed from the data collected on single peptide gels 
or PEGLM (cell behaviors = cell attachment, single cell 
area, large cluster area, % clustered, circularity, and attach-
ment following integrin α3 blocking). Next, a single met-
ric (ex. cell attachment) was removed from the training set 
and Principal Components Regression was performed (in 
Prism GraphPad) in order to predict the results of gene 
expression. R2 values were calculated as a metric of good-
ness of fit of the predicted gene expression values com-
pared to the known gene expression; the removed data 
were then replaced in the training matrix and the process 
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was repeated for all six-cell behavior metrics of the train-
ing data.
Results
Laminin-mimetic peptide-functionalized gels 
promote NP cell attachment and rounded, 
clustered morphologies similar to PEGLM
NP cells attached to 15% LMP gels at levels greater than 
attachment to uncoated glass when gels were functional-
ized with one LMP; further cell attachment levels were not 
statistically different from 4% PEGLM (p > 0.05 for all 
comparisons; Figure 3(a)). Although cell attachment was 
similar between most gels functionalized with a single 
LMP, differences in cell attachment were observed 
between gels functionalized with A5G81 and those pre-
senting AG73 (p = 0.042; Figure 3(a)).
Cell clustering is phenotypic of juvenile NP cells, so we 
next sought to explore the relative appearance of single 
cells and cell clusters (Supplemental Figure 2). The fre-
quency of single cells and large clusters in adherent cells 
on PEGLM resembled those seen on the LMP gels 
(p > 0.21; Figure 3(b) and (c)). Furthermore, morpholo-
gies were generally similar amongst the LMP gel condi-
tions; only A5G81 and GD-6 showed differences in the 
percentage of single cells (p = 0.028; Figure 3(b)) and 
fewer large clusters formed on AG73 compared to GD-6 
(p = 0.045; Figure 3(c)).
In contrast to degenerative NP cells which become 
elongated and demonstrate large cell spread areas, juvenile 
NP cells often assume a rounded cell morphology with 
Figure 3. Stiff gels (15% PEG) functionalized with laminin-mimetic peptides promote cell attachment and morphologies similar 
to those seen in cells in culture on 4% PEGLM: (a) total cell attachment to the LMP gels after 24 h. Percentage of cells that were 
adherent as (b) single cells or (c) large cell clusters (4+ cells). Spread area for (d) single cells or (e) large clusters. (f) Circularity of 
single cells.
For all plots: data represents samples as obtained from three human subjects.
bars: mean ± standard deviation; gray dotted line: average value on 4% PEGLM; gray solid line: average value on glass.
Comparing amongst single peptides: *p < 0.05, #p < 0.09; comparing to PEGLM: ^p < 0.05 and &p < 0.09.
8 Journal of Tissue Engineering 
relatively small spread areas. Therefore, the cell spread 
areas and circularity of cells was also quantified. While 
statistically significant differences were seen in cell spread 
area for single cells cultured on A5G81, IKVAV, and AG73 
compared to PEGLM (p = 0.0018, p = 0.0022, and 
p < 0.00010 respectively; Figure 3(d)), all single cells on 
LMP gels showed areas that were reduced compared to 
cells on glass. Similar single cell areas were observed 
amongst most LMP gel conditions (Figure 3(d)), although 
single cell areas were larger on AG73 than they were on 
GD-6 (p = 0.045) and the difference between P4 and AG73 
trended toward significance (p = 0.085). Likewise, the 
average size of large cell clusters on LMP gels were more 
similar to those on PEGLM than glass (Figure 3(e)). Large 
clusters on IKVAV had greater areas than those on PEGLM 
(p = 0.0092) and differences in large cluster size between 
PEGLM and P4 or AG73 trended toward significance 
(p = 0.069 and p = 0.053 respectively). YIGSR promoted 
the largest cluster size and showed altered cell cluster size 
compared to IKVAV (p = 0.032; Figure 3(f)). Only AG73 
demonstrated circularity that differed compared to PEGLM 
(p = 0.0082) though circularity also differed between 
A5G81 and AG73 (p = 0.017) and trended toward signifi-
cance for GD-6 and AG73 (p = 0.082). Understanding the 
morphological characteristics of cells on these substrates 
provides context for how the cells are sensing the underly-
ing biomaterial.
Laminin-mimetic peptides activate 
mechanosensitive pathways
Cell attachment, morphology, and spreading are known to 
be downstream of cell receptor interactions with extracel-
lular ligands and subsequent activation of cell signaling 
pathways. Paxillin-positive focal adhesions were visual-
ized on a subset of LMP gels and were observed to form in 
the adherent cells (data for A5G81 and IKVAV shown in 
Supplemental Figure 3(a)). Additionally, intracellular 
signaling cascades downstream of integrin binding and 
focal adhesion formation were shown to be activated by 
LMP gels. ERK 1/2 phosphorylation occurred on both 4% 
PEGLM and 15% LMP gels and was similar in both sys-
tems (Figure 4(a); p > 0.16 for all comparisons); further, 
activation of ERK1/2 was similar amongst most LMP gels, 
Figure 4. Stiff LMP gels demonstrate similarities in bioactivity but differences in bio-inductive capabilities. Phosphorylation of major 
signaling proteins: (a) ERK 1/2 and (b) GSK3β. For (a) and (b) gray dotted line = average value on 4% PEGLM; comparing amongst 
single peptides: *p < 0.05. (c) Cell attachment following blocking of integrin α3; relative cell attachment = 100*(integrin-blocked/
IgG control); *p < 0.05 compared to IgG-treated cells. (d) Radar plots depicting average expression for phenotypic markers relative 
(relative gene expression = 2−∆∆Ct comparing to housekeeping genes and syndecan-binding peptide AG73); scales adjusted as needed 
to show gene expression on LMP gels.
For all plots: data represents samples as obtained from at least three human subjects.
bars: mean ± standard deviation.
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although IKVAV had increased ERK 1/2 phosphorylation 
compared to both YIGSR and GD-6 (p = 0.038 and 
p = 0.023 respectively). GSK3β phosphorylation showed 
similar trends; LMP gels promoted similar protein phos-
phorylation as PEGLM (Figure 4(b); p > 0.62 for all com-
parisons) and only differences between P4 and A5G81 
reached levels of statistical significance (p = 0.022). 
Examination of another mechanosensitive pathway, YAP/
TAZ, revealed that YAP was found to be present in both 
cytoplasmic and nuclear compartments when cells were 
cultured on a subset of LMP gels (IKVAV and A5G81; 
Supplemental Figure 3(b)). Additionally, quantification of 
nascent protein production in these same representative 
gels demonstrated that culture on LMP gels promoted both 
intracellular biosynthesis and extracellular protein deposi-
tion (Supplemental Figure 3(c)). Together, these findings 
provide evidence that the LMPs are bioactive and that cells 
cultured on single LMP-functionalized gels are able to sig-
nal through similar pathways as they do when they interact 
with full-length laminin. Furthermore, inhibition of integ-
rin α3 function reduced cell attachment (p < 0.05) to all 
LMP gels (Figure 4(c)). Thus, the activation of these path-
ways is likely, at least in part, regulated by integrin-medi-
ated mechanisms.
Laminin-mimetic peptides promote differential 
expression of markers of juvenile NP phenotype
Five markers of NP phenotype (ACAN, CDH2, GLUT1, 
COL1A1, and COL2A1) were quantified in cells cultured 
on the hydrogels to screen LMPs for their ability to shift 
adult degenerative NP cells toward a juvenile-like state. 
Patterns of gene expression differed between integrin-
binding and syndecan-binding LMP gels. IKVAV and 
GD-6 promoted the greatest expression of all phenotypic 
markers (Figure 4(d) left). Expression of COL2A1 and 
COL1A1 were highest in GD-6, and IKVAV promoted the 
greatest expression of GLUT1, CDH2, and ACAN. YIGSR 
and P4 demonstrated intermediate gene expression pro-
files (Figure 4(d) middle). However, A5G81 promoted 
downregulations of the phenotypic markers (Figure 4(d) 
right). These findings indicate that amongst the LMPs 
tested, IKVAV and GD-6 may have the greatest effect in 
promoting the NP cell phenotype.
Principal components analysis (PCA) and 
Pearson correlations provide insights on co-
regulated cell behaviors for NP cells cultured 
on gels functionalized with laminin-mimetic 
peptides
PCA was conducted to reduce dimensionality of the data 
and to identify clustering amongst LMP conditions and 
cell behaviors. 75% of total variance was captured by PCs 
1–4; 41% and 17% of the variance were captured by PCs 1 
and 2 respectively (Figure 5(a)). Examination of the result-
ant scores from PCA revealed separation of IKVAV and 
GD-6 from the other LMPs by PC1 (Figure 5(b)). 
Additionally, to a lesser degree, PC2 was able to separate 
PEGLM from the LMPs. The loadings from the PCA dem-
onstrated that gene expression of phenotypic markers 
strongly correlated with PC1 and the gene expression met-
rics clustered together closely in both PC1 and PC2. Single 
cell spread area and cell circularity most strongly corre-
lated with PC2, however, these two metrics were nega-
tively correlated with each other (Figure 5(c)).
These trends were further confirmed through the cor-
relation matrix (Figure 5(d)) which demonstrated strong 
positive correlations (r > 0.5) amongst the phenotypic 
markers, moderate negative correlations between single 
cell area and circularity (r = −0.61) as well as cell attach-
ment and single cell area (r = −0.45), and weak correlations 
between cell attachment and expression of collagens 
(r = −0.35). These findings corroborate that LMP gels 
IKVAV and GD-6 were most different from other sub-
strates based on the gene expression profiles they promote 
in NP cells. In order to determine the ability of subsets of 
the data to predict NP phenotypic markers, “leave one out” 
validation was performed in combination with principal 
components regression. These data demonstrated that 
removing the integrin blocking data reduced the ability to 
predict ACAN expression (Supplemental Figure 4). 
Further, the ability to predict CDH2, GLUT1, COL2A1, 
and COL1A1 expression was reduced upon removal of the 
single cell spread area and single cell circularity data 
(Supplemental Figure 4). These findings suggest that 
ACAN expression may be most strongly related to integ-
rin-mediated mechanotransduction, while the other mark-
ers tested may be more strongly regulated by cell shape 
and cellular contractility.
Dual presentation of integrin-binding and 
syndecan-binding peptides promote similar 
morphologies as gels functionalized with a 
single peptides
Having characterized gels functionalized with a single 
integrin-binding or syndecan-binding peptide, next gels 
were formulated to present both an integrin-binding pep-
tide and the syndecan-binding peptide AG73 (dual peptide 
gels). Dual peptide gels demonstrated patterns of cell 
attachment that largely replicated those seen for the gels 
functionalized with a single integrin-binding or syndecan-
binding peptide (Figure 6(a)) and showed patterns of 
attachment that were between those seen on glass and 
PEGLM. Differences in cell attachment between single 
and dual peptides was only observed for the 
integrin-binding peptide GD-6; co-presentation of GD-6 
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Figure 5. Principal components analysis (PCA) and Pearson correlations were utilized to reduce dimensionality and observe 
co-regulated behaviors for single peptide gels: (a) percent of variance explained by each PC (black dots) and cumulative variance 
(gray bars), (b) PC Scores shows clustering by LMP; peptides were color coded, size of dot indicates syndecan-binding LMP (largest 
dot), integrin-binding LMP (medium dot), or full-length protein (smallest dot), (c) loadings show correlations between cell behavior 
metrics, and (d) Pearson correlation matrix (r values shown with the color map).
and AG73 demonstrated increased cell attachment com-
pared to GD-6 alone (p = 0.028), but not to AG73 alone 
(p = 0.13).
The morphology of attached cells to dual peptide gels 
was quantified and compared to gels functionalized with a 
single LMP. Dual presentation of YIGSR and AG73 or P4 
and AG73 increased single cell attachment compared to 
YIGSR (p = 0.063) or P4 (p = 0.0025) alone (Figure 6(b), 
Supplemental Figure 2). In contrast, all dual peptide condi-
tions promoted attachment of single cells at levels similar 
to AG73 alone (p > 0.26; Figure 6(b)). For all dual peptide 
gels, single cell attachment was greater than PEGLM and 
below glass (Figure 6(b)). Attachment as large clusters 
(4+ cells) to dual peptide gels was reduced for P4 and 
AG73 (p = 0.0170) and for A5G81 and AG73 (p = 0.044), 
compared to the respective single integrin-binding peptide 
(Figure 7(a)). However, only IKVAV + AG73 showed 
differential large cell cluster formation compared to AG73 
alone (p = 0.0065; Figure 7(a)). Large cell cluster forma-
tion was most similar to PEGLM for dual peptide gels that 
contained IKVAV and AG73 or GD-6 and AG73.
We next quantified the cell spread areas for the single 
cells or large cell clusters. Spread area for single cells was 
increased for all dual peptide conditions compared to 
AG73 alone (p < 0.062 for all comparisons; Figure 6(c)), 
however, compared to gels functionalized with a single 
integrin-binding peptide, only GD-6 + AG73 showed dif-
ferent single cell spread area (p = 0.059). Large cell cluster 
area was decreased on dual peptide gels compared to both 
single peptide gels for YIGSR (p = 0.058 compared to 
AG73 alone, p = 0.015 compared to YIGSR alone, Figure 
7(b)). Cells cultured on gels functionalized with P4 and 
AG73 had similar cell areas compared to gels which pre-
sented P4 only (p = 0.17), but reduced cell cluster area 
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Figure 6. Characterization of PEG gels with integrin-binding and syndecan-binding peptides and single cell behaviors: (a) total cell 
attachment for cells seeded on single or dual peptide gels, (b) cell attachment to single or dual peptide gels as single cells, (c) cell 
spread area for single cells, (d) single cell circularity.
For all plots: data obtained from at least three human subjects.
bars: mean ± standard deviation; dotted line: average value on 4% PEGLM; solid line: average value on glass.
t-Tests comparing integrin binding peptide to dual peptide gels: *p < 0.05, **p < 0.01, ***p < 0.001, #p < 0.09; comparing dual peptide gels to 
syndecan-binding peptide: %p < 0.05, χp < 0.09.
compared to the AG73 gels (p = 0.029). Additionally, gels 
with IKVAV + AG73 had increased cell areas compared to 
IKVAV (p = 0.010) but not AG73 (p = 0.20). For both sin-
gle cells and clusters adherent to dual peptide gels, spread 
cell areas were observed to be between the size of cells/
clusters on soft PEGLM and glass.
All single cells on LMP gels assumed a geometry that 
was generally round (circularity > 0.7), though several sta-
tistically significant differences were observed as a func-
tion of LMP presentation (Figure 6(d)). Functionalization 
of gels with both integrin and syndecan binding peptides 
promoted significantly reduced cell circularity for A5G81 
(p = 0.0001) compared to the gel condition with A5G81 
alone. Additionally, gels presenting YIGSR + AG73 and 
GD-6 + AG73 promoted increased cell circularities com-
pared to gels with only the syndecan binding peptide AG73 
(p = 0.08 and p = 0.037).
Gene expression of phenotypic markers was generally 
highest on gels functionalized with a single integrin-bind-
ing peptide (Figure 7(c)). For example, expression of 
COL1A1, COL2A1, and GLUT1 was highest on YIGSR 
gels compared to AG73, YIGSR + AG73, or PEGLM 
gels. Expression of ACAN was similar between YIGSR + 
AG73, PEGLM, and AG73 gels, and higher on these gels 
than on gels functionalized with YIGSR alone. In contrast, 
CDH2 expression was similar between AG73, YIGSR, 
and PEGLM gels and lowest on YIGSR + AG73.
Dimensionality reduction of dual and single peptide 
data together demonstrated that PC1 and PC2 accounted 
for 39% and 16% of total variance respectively (Figure 
8(a)). As with the single peptide data (Figure 5), it was 
observed that IKVAV and GD-6 (without AG73) both sep-
arated from the rest of the data along PC1 (Figure 8(b)). 
Neither PC1 nor PC2 was able to separate the other single 
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Figure 7. Characterization of PEG gels with integrin-binding and syndecan-binding peptides on the behavior of cells in large 
clusters and gene expression profiles: (a) attachment to gels as large clusters, (b) quantification of spread area for large cell clusters, 
(c) radar plots of relative gene expression for NP phenotypic markers for cells cultured on single peptide gels, dual peptide gels, or 
PEGLM (relative gene expression = 2−∆∆Ct comparing to housekeeping genes and syndecan-binding peptide AG73); scales adjusted to 
capture the respective data on a single axis.
For all plots: data from at least three human subjects.
bars: mean ± standard deviation; dotted line: average value on 4% PEGLM; solid line: average value on glass.
t-Tests comparing integrin binding peptide to dual peptide gels: *p < 0.05; comparing dual peptide gels to syndecan-binding peptide: %p < 0.05, χp < 0.09.
and dual LMP conditions. Gene expression for CDH2, 
GLUT1, COL2A1, and COL1A1 showed strong correla-
tions with PC1 (Figure 8(c)); whereas percentage of clus-
tered cells was the most strongly correlated to PC2 (Figure 
8(c)). The correlation matrix confirmed that while most 
genes were associated, only weak correlations were seen 
between ACAN and COL2A1 and COL1A1 (Figure 8(d)). 
The data from both single and dual peptide gels also dem-
onstrated negative correlations between cell circularity 
and cell area, corroborating that a greater degree of circu-
larity (rounder cells) is associated with decreased cell 
spread areas.
Discussion
Data from the present study demonstrate the ability of an 
array of LMPs conjugated to a 15% PEG biomaterial sys-
tem to regulate NP cell behaviors in a manner similar to 
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4% PEGLM. The use of peptides offers advantages over 
full-length proteins in both economic value and ligand 
specificity. Furthermore, this polymer system is able to 
rapidly crosslink in situ while retaining the ability to 
encapsulate and deliver cells to an IVD defect.80 Herein we 
have screened these peptides for their ability to regulate 
NP cell attachment, morphology, and phenotype, con-
firmed the bioactivity of the LMPs, and have identified 
cell receptors that facilitate mechanotransduction between 
the cells and the biomaterials (Table 3). Additionally, we 
have shown that integrin-mediated mechanisms may be 
most able to de-differentiate degenerative human NP cells 
toward a juvenile-like state.
Previous studies have identified the ability for LMPs to 
modulate cell behaviors in peptide sequence- and cell source-
dependent manners. Data from the present study similarly 
demonstrated that NP cell attachment and morphology met-
rics such as cell spread area and circularity showed variabil-
ity amongst the peptide-conjugated hydrogels. Notably, stiff 
gels functionalized with 100 µM of a single LMP promoted 
behaviors that generally resembled those of cells on soft gels 
functionalized with full-length LM-111 and corroborate 
prior findings of studies which have conjugated LMPs to 
additional polymeric backbones including polyacrylamide40 
and alginate (unpublished data). This is likely in part associ-
ated with the observation that interactions between NP cells 
and the LMP-functionalized gel activated mechanosensitive 
pathways ERK 1/2 and GSK3β at levels comparable to that 
seen in soft PEGLM. Engagement of these pathways is 
known to contribute to regulation of gene expression,81,82 
focal adhesion formation,83 and cytoskeletal remodeling84–86 
at early time points, all of which ultimately result in cell 
viability,83–85,87 cell cycle progression,85,88 and motility.84 
Additionally, these cellular processes modulate cell differen-
tiation or phenotype.84,89 Prior research has demonstrated 
that gene expression of NP cell markers can be regulated 
through microenvironmental conditions such as substrate 
stiffness, ligand presentation and density, and cell shape as 
Figure 8. Principal components analysis (PCA) and Pearson correlations were utilized to reduce dimensionality and observe 
co-regulated behaviors for single and dual peptide gels: (a) percent of variance explained by each PC (black dots) and cumulative 
variance (gray bars), (b) PC Scores shows clustering by LMP; peptides were color coded, size of dot indicates full-length protein 
(smallest dot), single LMP peptide (medium sized dots), dual LMP peptide (largest dot), (c) Loadings show correlations between cell 
behavior metrics, and (d) Pearson correlation matrix (r values shown with the color map).





































































































































Figure 9. NP cell morphology, biosynthesis, and phenotype 
can be modulated through biomaterials which present full-
length laminins or LMPs that promote intracellular signaling 
and development of cell-cell and cell-matrix interactions. Figure 
created with BioRender.com.
well as relative contributions of cell-cell and cell-matrix 
interactions (Figure 9).59,70,90–92 Statistical modeling in the 
present study corroborates these findings and further sug-
gests that engagement of integrin α3 may specifically pro-
mote ACAN expression, while CDH2, GLUT1, COL2A1, 
and COL1A1 transcription may be promoted by processes 
further downstream of integrin activation including cell 
shape and cytoskeletal regulation. Despite all the single-
LMP gels promoting protein phosphorylation at levels com-
parable to the full-length laminin, differences were observed 
between peptides and the full protein for expression of the 
phenotypic markers. Gene expression of phenotypic markers 
was greatest on the gels functionalized with IKVAV (maxi-
mum expression for ACAN, CDH2, and GLUT1) and GD-6 
(maximum expression for COL2A1 and COL1A1) and the 
lowest expression of phenotypic markers was seen on the 
A5G81 gels. This finding indicates that specific LMPs may 
be particularly well-suited to drive biosynthetic activity in 
NP cells.
Having characterized biomaterials functionalized with a 
single LMP, gels were next made that presented an integrin-
binding LMP in combination with the syndecan-binding 
LMP, AG73. Prior reports have indicated a synergistic 
interaction between integrins and syndecans93–96 in driving 
cell attachment and intracellular signaling. Thus, a hypoth-
esis for the present study was that dual presentation of an 
integrin-binding peptide with AG73 would promote 
increased NP cell attachment and expression of phenotypic 
markers as compared to single peptide presentation alone. 
The metrics for cell attachment, cell/cluster morphology, 
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and gene expression generally demonstrated that stiff gels 
functionalized with 100 µM of total LMP were able to pro-
mote similar behaviors as the soft PEGLM. However, when 
comparing between the single and dual peptide gels, the 
presence of AG73 tended to be antagonistic to the effects 
observed for the integrin-mediated modulation of NP cell 
behavior on dual peptide-functionalized hydrogels. For 
example, gene expression of NP markers was generally 
greatest on the single peptide gel, and lowest on the dually-
functionalized hydrogel. This effect may be in part due to 
syndecan phosphorylation resulting in integrin endocytosis 
and trafficking away from the membrane and thereby 
altered integrin expression and a decreased ability to inter-
act with the integrin-binding LMPs in the gel, as has been 
reported in prior studies.93,95,97–99 Future experimentation 
would be needed to characterize the kinetics of expression 
of adhesive proteins, focal adhesion turnover, and intracel-
lular signaling in order to elucidate the relative roles of 
integrins and syndecans in mediating degenerative NP cells 
interactions with the extracellular environment.86,93,95,99–101
While the dual presentation of integrin-binding and 
syndecan-binding peptides did not elicit a synergistic 
response in the present study, combinations of other pep-
tides may have the beneficial effects not specifically 
observed here.102 For example, combining IKVAV and 
GD-6 which each promoted the greatest expression of dif-
ferent phenotypic markers may result in an additive or 
synergistic effect and warrants future study. While we 
examined a subset of integrin-binding LMPs, the full-
length laminin protein contains many other integrin-bind-
ing peptides which have not yet been screened for use in 
NP cell culture. Further characterization of the LMP con-
ditions used herein (or the introduction of other LMPs) 
should expand on the results of the present study to 
include the quantification of a broad range of phenotypic 
markers at the protein level and the results of focal adhe-
sion formation, nascent protein production, and YAP 
localization that were quantified for A5G81- or IKVAV-
functionalized gels should be expanded to include all gel 
conditions. Another limitation of the present study was 
the use of 2D culture; additional experimentation will be 
needed to explore the integrin and syndecan mediated 
mechanisms in 3D and under physiologic mechanical 
loading conditions. Lastly, here only degenerative cells 
were used, however, characterizing juvenile NP cell inter-
actions with LMP gels may demonstrate differences in 
mechanotransduction between healthy and pathological 
samples.
Overall the data presented demonstrate characterization 
of a library of bioactive materials that present either a sin-
gle LMP or a combination of an integrin- and syndecan-
binding peptide on a PEG-hydrogel platform. The results 
from assessments of cell attachment, morphology, and 
phenotypic measures validate the ability of this engineered 
biomaterial constructed from 15% PEG to recapitulate 
behaviors elicited by soft gels prepared from 4% PEG and 
functionalized with full-length proteins. Use of a 15% 
PEG hydrogel platform, with a measured compressive 
stiffness of 10.5 kPa and rapid gelation time (~10 min), has 
demonstrated success with regulating the NP cell pheno-
type and global transcriptome54,103 and can be injected into 
an IVD defect.80 These findings are clinically relevant as 
stiffer, injectable and in situ crosslinking biomaterials have 
advantages as a vehicle to deliver cells in a regenerative 
engineering strategy to the degenerative disc space.
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